French biotech EG 427 has had success with its urinary incontinence DNA therapy, EG110A, showing a more than 80% reduction in ...

With layoffs happening at biopharma companies of all sizes, some may wonder which jobs are safest. Talent acquisition experts ...

Treatment introduces an expansion of the scope of gene therapies that might lead to similar treatments for neurodegenerative ...

I cried with every single patient,” Sung says. “It just was this crazy feeling that, for the patients and families, almost can’t feel real.” The treatment, known as AMT-130, is delivered deep into the ...

Categorizes Mucopolysaccharidosis III therapeutic companies by development stage: early, mid, and late-stage. Highlights ...

A beta blocker called propranolol has become popular for tempering anxiety and is generally safe, but it isn’t without risks.

The Japanese pharmaceutical company, which had made cell therapy a priority a few years ago, aims to partner its work while ...

How cell and gene therapy developers can lessen the chances of receiving FDA complete response letters through the use of ...

In a preclinical study, UC Davis Comprehensive Cancer Center scientists have developed a highly targeted gene therapy that ...

Now what this therapy is, is that it's basically a gene knockout therapy, and you give this to the patient via IV route for ...

After years of heartbreak, researchers have found an experimental treatment that can slow the progression of Huntington’s ...

The entire rationale behind this multi-pronged screening was the discovery of checkpoints or regulators that are critically involved in inducing suppression in NK cells under these diverse negative ...